| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| humant immunglobulin G 10 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 10 g injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 20 g injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 2,5 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 10 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 5 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| humant immunglobulin G 16 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| Human immunoglobulin IgG 200mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| Product containing human immunoglobulin G (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Radioisotope labeled human immunoglobulin G |
Is a |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| Technetium (99m-Tc) human immunoglobulin G |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| Product containing only human immunoglobulin G (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing only human immunoglobulin G in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Product containing human immunoglobulin G in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Radioisotope labeled human immunoglobulin G |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
|
| Human immunoglobulin G 6 G powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
| Human immunoglobulin G 6 G powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human immunoglobulin G (substance) |
Inferred relationship |
Some |
1 |
FHIR